Records containing: Plasma Cell Myeloma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2024-10-26
Cryocompression for Bortezomib-Induced Peripheral Neuropathy Among Multiple Myeloma Patients
CLINICAL_TRIALS study record update · 2024-08-09
Dysregulation of Glutamine Utilization in the Pathogenesis of Multiple Myeloma
CLINICAL_TRIALS study record update · 2024-07-03
Phase II Study of Pembrolizumab as Salvage Therapy Among Multiple Myeloma Patients Progressing on CAR-T Cell Therapy
CLINICAL_TRIALS study record update · 2024-07-01
A Phase 2 Evaluation of Daratumumab-Based Treatment in Newly Diagnosed Multiple Myeloma Patients With Renal Insufficiency
CLINICAL_TRIALS study record update · 2024-06-21
A Randomized Phase II Study of DaRatumumab, Ixazomib, and Dexamethasone vs Daratumumab, Bortezomib (VElcade) and Dexamethasone Followed by Daratumumab-Ixazomib-Dexamethasone in Newly Diagnosed Multiple Myeloma (DeRIVE Study)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2024-06-14
A Phase 1/2 Study to Evaluate Safety, Pharmacokinetics and Efficacy of Isatuximab in Combination With Cemiplimab in Patients With Relapsed/Refractory Multiple Myeloma
CLINICAL_TRIALS study record update · 2024-04-16
A Feasibility Study of Chaplain-Delivered Compassion Meditation for Patients Receiving Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2024-04-02
A Phase II Trial of Haploidentical Allogeneic Stem Cell Transplantation Utilizing Mobilized Peripheral Blood Stem Cells
CLINICAL_TRIALS study record update · 2024-03-12
A Phase II Study of Enhancing Anti-Tetanus Vaccine Response After Autologous Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2024-03-12
A Pilot/Feasibility Trial of 64Cu-DOTA-Daratumumab Positron Emission Tomography in Patients With Newly Diagnosed or Relapsed Multiple Myeloma
CLINICAL_TRIALS study record update · 2024-01-31
A Phase I Trial Evaluating Escalating Doses of 211At-Labeled Anti-CD38 Monoclonal Antibody (211At-OKT10-B10) Combined With Melphalan as Conditioning Prior to Autologous Hematopoietic Cell Transplantation for Patients With Multiple Myeloma
CLINICAL_TRIALS study record update · 2024-01-29
A Dose Escalation, Safety, Pharmacokinetic, Pharmacodynamic and Preliminary Efficacy Study of SAR650984 (Isatuximab) Administered Intravenously in Combination With Bortezomib - Based Regimens in Adult Patients With Newly Diagnosed Multiple Myeloma Non Eligible for Transplantation or No Intent for Immediate Transplantation
CLINICAL_TRIALS study record update · 2024-01-02
A Phase II Study of Xisomab 3G3, a Monoclonal Antibody Preventing the Activation of FXI by FXIIa, for the Prophylaxis of Catheter-Associated Thrombosis
CLINICAL_TRIALS study record update · 2023-08-07
The Prophylactic Use of Loratadine for Granulocyte-Colony Stimulating Factor (G-CSF) Induced Bone Pain in Multiple Myeloma Patients Undergoing Stem Cell Mobilization
CLINICAL_TRIALS study record update · 2023-08-01
The VICTORY Study: A Phase I Study of Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation
CLINICAL_TRIALS study record update · 2023-07-13
A Phase 1b Study of SAR650984 (Anti-CD38 mAb) in Combination With Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
CLINICAL_TRIALS study record update · 2023-06-26
Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
CLINICAL_TRIALS study record update · 2023-05-03
A Phase 2 Trial of the Discussion of Cost (DISCO) App as an Intervention to Improve Financial Outcomes in Hematologic Cancer Patients
CLINICAL_TRIALS study record update · 2023-04-10
Feasibility of Strength Training and Impact on Pain and Quality of Life in Patients With Multiple Myeloma
CLINICAL_TRIALS study record update · 2023-02-21
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT-803
CLINICAL_TRIALS study record update · 2023-02-16
Phase I Clinical Trial Using an Engineered Peripheral Blood Graft for Haploidentical Transplantation
CLINICAL_TRIALS study record update · 2023-02-13
Randomized, Open Label, Multicenter Study Assessing The Clinical Benefit Of Isatuximab Combined With Carfilzomib (Kyprolis®) And Dexamethasone Versus Carfilzomib With Dexamethasone In Patients With Relapse And/Or Refractory Multiple Myeloma Previously Treated With 1 to 3 Prior Lines
CLINICAL_TRIALS study record update · 2022-09-21
Phase 1/2 Trial of Ixazomib in Combination With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis
CLINICAL_TRIALS study record update · 2022-07-05
Alternating the Administration of Ixazomib and Lenalidomide as Maintenance Therapy After Autologous Transplant for Treating Multiple Myeloma
CLINICAL_TRIALS study record update · 2022-05-23
Phase 2 Trial of Pomalidomide, Ixazomib and Dexamethasone in Patients With Multiple Myeloma With Extramedullary Disease or Plasma Cell Leukemia